New York, NY (PRWEB) March 13, 2014
The prescription drug safety center DrugNews.net is announcing updated information on the site for patients taking testosterone replacement therapies, or “low-T” drugs. A recent lawsuit alleges the drug Testim caused a male patient to suffer a stroke*.
This comes amid a report that the FDA has launched an investigation into testosterone drug heart attack, stroke and death risks based on new studies**.
DrugNews is a free resource for patients taking popular prescription drugs. By sharing the latest drug warnings, product recalls and lawsuit news, visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.
Last year, more than 5.5 million men filled prescriptions for low-T drugs like AndroGel, Axiron, Testim and AndroDerm***. However, recent studies question their safety.
The resource center has added a study from UCLA and the National Institute of Health finding men over 65 and those with a history of heart disease had double the rate of heart attack after starting testosterone therapy****.
In November, the American Medical Association also released data showing older men or those with prior heart disease had a 29% increased rate of heart attacks, stroke or death from low-T drugs*****.
A number of men have already filed a testosterone lawsuit in an Illinois federal court alleging drugs like AndroGel caused heart attack or stroke without warning***.
Now, DrugNews has learned of a new case filed in California federal court, in which a male patient alleges he suffered a stroke after taking the drug Testim*.
Lawyers are offering help to those affected. Anyone who suffered a heart attack or stroke after using a low-T drug like AndroGel, Axiron, Testim or AndroDerm is urged to visit DrugNews or speak with a lawyer about their legal rights as soon as possible. DrugNews only recommends lawyers who have already handled testosterone lawsuits.
For more information on the research, side effects and litigation news related to testosterone drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*The Examiner, 3/12/14; westvirginia.legalexaminer.com/fda-prescription-drugs/lawsuit-filed-against-makers-of-testim-a-form-of-testosterone-therapy-treatment/ ; Joseph Myers v. Auxilium Pharmaceuticals, Inc., 8:14-cv-00278 U.S. Dist. Ct, Central District of California
**FDA, 1/31/14; http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
***Bloomberg, 2/5/14; bloomberg.com/news/2014-02-05/abbott-labs-sued-by-five-men-claiming-androgel-injuries.html; Aurecchia v. AbbVie Inc., 14-cv-00772, U.S. Dist. Ct, Northern District of Illinois (Chicago); Marino v. AbbVie Inc., 14-cv-00777 U.S. Dist. Ct, Northern District of Illinois (Chicago)
****Public Library of Science, 1/29/14; plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805
*****JAMA 11/5/13; media.jamanetwork.com/news-item/testosterone-therapy-following-coronary-angiography-associated-increased-risk-adverse-outcomes/